Last Minute Lecture

Emerging Psychiatric Treatments and Safe Medication Discontinuation — Chapter 22 Summary from Clinical Psychopharmacology for Therapists Chapter 22 of Clinical Psychopharmacology for Therapists explores two critical themes in modern psychiatric care: the rise of emerging treatments such as ketamine and psychedelics, and the often-overlooked process of safely discontinuing psychotropic medications . With mental health care evolving rapidly, this chapter provides both hope and caution—highlighting new possibilities for treatment-resistant conditions and the importance of tapering medications to avoid serious withdrawal effects. 🎥 Watch the full video breakdown below for a podcast-style summary of this insightful chapter: Ketamine and the NMDA Receptor Revolution Originally developed as an anesthetic, ketamine is now at the forefront of research into treatment-resistant depression . It functions as an NMDA receptor antagonist , targeting the glutamate system rather than sero...

Herbal Supplements and Emerging Psychiatric Treatments — Chapter 21 Summary from Clinical Psychopharmacology for Therapists As mental health care continues to evolve, more individuals are exploring alternatives to traditional psychiatric medications. Chapter 21 of Clinical Psychopharmacology for Therapists takes a close look at the growing popularity of herbal supplements , dietary products , and emerging psychiatric treatments . This chapter balances the hope of new approaches with the caution required when combining these interventions with conventional psychiatric care. 🎥 Watch the full podcast-style video below for a guided summary of Chapter 21: Why People Are Turning to Complementary and Alternative Medicine (CAM) The chapter opens by addressing the rise of Complementary and Alternative Medicine (CAM) in mental health. Many individuals seek "natural" remedies due to concerns about the side effects of psychiatric drugs, stigma, or a desire for more holistic ...